Asset 17
Skip to content
Continuing Education
Online Orders
Continuing Education
Online Orders
Asset 17
  • Home
  • Services
  • Facilities
  • Software
  • Clinical Trials
  • Contact

Press Release

Press Release Articles

2 Articles

UPPI to partner with Telix on development of new Prostate Cancer Imaging Agent

Telix Pharmaceuticals Limited (ASX: TLX) is a global biopharmaceutical company based in Melbourne. The company develops...

Read More

Amyloid PET changed clinical management in 60% of patients with dementia

Amyloid PET imaging greatly influenced the clinical management of patients with mild cognitive impairment (MCI)...

Read More

Asset 17
  • Home
  • Services
  • Facilities
  • Software
  • Clinical Trials
  • Contact

©2023 Shertech Nuclear. All rights reserved.   |  Sitemap

Web Design by: Drum Creative
Top